Abstract
Objective
Periodontitis and various noncommunicable diseases (NCDs) have been proposed to have a bidirectional relationship. The purpose of this umbrella review is (1) to synthesize the evidence and (2) to grade the strength and certainty of the scientific evidence regarding the bidirectional association between periodontitis and NCDs.
Data sources
Electronic databases were systematically searched from January 2021 and July 2024; MEDLINE (via PubMed), Embase and SciELO.
Data selection and extraction
Potential epidemiologic systematic reviews with meta-analysis that studied the bidirectional association between periodontitis and NCDs were identified by two independent reviewers and filtered by title and abstract according to the selection criteria. The strength and the quality and certainty of the evidence was assessed according to the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) guide. 561,554 potential results were identified. After removing duplicates and excluding records deemed ineligible by automated filters, 450 results were screened by title and abstract. This process led to 41 records being appraised in full-text. Of these, 17 were further excluded leaving a total of 24 systematic reviews that met the inclusion criteria.
Data synthesis
24 systematic reviews with a total of 32 NCDs were appraised and consolidated. Risk of bias assessment indicated that 21 systematic reviews (87.5%) demonstrated low bias (high quality), 2 had medium bias, and 1 exhibited high bias (low quality). Key issues identified included the formulation of explicit research questions, critical appraisal, data extraction, and publication bias. The association between periodontitis and NCDs was strong in 1 systematic review, moderate in 8, weak in 10 and absent in 7 systematic reviews. The strength of the association between NCDs and periodontitis was moderate in 6 systematic reviews and weak in 3 systematic reviews. The size of the reported effect (odds ratio/risk ratio/hazard ratio) was broader with increasing strength. Although data supports the association between periodontitis and some NCDs, and to a lesser extent between some NCDs and periodontitis, the certainty of the evidence was classified as low to very low.
Conclusions
There is some data that, with varying degrees of association and low to very low certainty, provide evidence that periodontitis may be a potential risk factor for some NCDs and vice versa.
Subject terms: Periodontitis, Dental public health, Occupational health
Key points.
Clinicians should be aware of the possible links between oral and systemic health but should interpret these associations with caution.
The review revealed methodological issues in systematic reviews, such as publication bias, a lack of specific research goals and diversity in critical appraisal and data extraction procedures.
When counseling patients, healthcare providers should avoid exaggerating the role of periodontitis in systemic disorders. Instead, they should stress the well-established benefits of periodontal care, including improved oral health and lower local inflammation, while remaining open to new findings.
Introduction
Periodontitis is a chronic inflammatory disease primarily caused by a dysbiotic bacterial biofilm adhered to dental surfaces with the potential to exacerbate systemic inflammation, consequently leading to or worsening conditions such as cardiovascular diseases, diabetes, and respiratory diseases. The inflammatory mediators released during periodontal infections, such as cytokines and prostaglandins, can enter the bloodstream, contributing to systemic inflammation and promoting the development of systemic health complications [1, 2].
Noncommunicable diseases (NCDs) are medical conditions that cannot be transmitted directly from one person to another. They are usually chronic and progress slowly, frequently lasting for many years or even a lifetime. Cardiovascular complications, malignancies, chronic respiratory diseases, and diabetes are the four most common types of NCDs. These disorders are caused by a mix of genetic, physiological, environmental, and behavioral factors. Tobacco use, physical inactivity, a poor diet, and excessive alcohol consumption all contribute to metabolic alterations such as hypertension, obesity, hyperglycemia, and hyperlipidemia [3]. The impact of NCDs on human health is considerable, imposing a significant burden on individuals, healthcare systems, and economies around the world. NCDs are the main cause of mortality worldwide, accounting for over 74% of all deaths each year. They cause extended disability, lower quality of life, and higher healthcare costs. The chronic nature of NCDs involves long-term management and care, which places significant strain on healthcare resources. Furthermore, NCDs disproportionately impact low- and middle-income nations, where healthcare systems may be less suited to manage the complex and long-term care needed [3].
Periodontitis and some NCDs have a bidirectional relationship, meaning that the existence of one condition might influence the severity or progression of the other. This interaction is mostly explained by the systemic inflammatory response and immunological regulation. In 2016, Monsarrat and coworkers conducted a search related to periodontal medicine and reported that 57 systemic conditions have hypothetically associated with periodontitis. Apart from cardiovascular conditions, diabetes and adverse pregnancy outcomes which have abundant evidence, other diseases included anemia, liver diseases, dyspepsia and ankylosing spondylitis [4].
The complex relationship between periodontitis and NCDs emphasizes the significance of comprehensive healthcare treatments that address both oral and systemic health. Clinicians must acknowledge the interconnectivity of various NCDs and use a holistic approach to diagnose and treat the patients. For example, addressing periodontal disease may help manage systemic inflammation, positively impacting illnesses like cardiovascular disease and diabetes [5]. Likewise, effectively managing systemic conditions can contribute to better periodontal health, highlighting the need for collaborative care between dental and medical professionals. This integrated approach can lead to improved overall health outcomes and quality of life for patients.
The abundant publication of systematic reviews has resulted in an overwhelming collection of research that can be both repetitive and contradicting, which can cause scientific, ethical, economic, and social consequences [6]. While systematic reviews are useful for combining primary research, their methodology, quality, and scope can vary greatly, resulting in a range of results and recommendations. The large volume of these reviews can lead to information overload, making it challenging for physicians, policymakers, and academics to identify the most relevant and high-quality data needed for evidence-based decision-making.
Umbrella reviews address these challenges by providing a comprehensive synthesis of systematic reviews and meta-analyses on a particular topic. They offer a higher level of evidence by critically appraising and integrating findings from multiple systematic reviews, thus delivering a more cohesive and reliable summary of the existing research. Umbrella reviews enhance the clarity and utility of the evidence base, highlighting areas of consensus and identifying gaps or inconsistencies in the literature. Therefore, the purpose of this umbrella review is (1) to synthesize the evidence and (2) to grade the strength and certainty of the scientific evidence regarding the bidirectional association between periodontitis and NCDs.
Methods
An umbrella review was conducted according to the recommendations of the JBI (Joanna Briggs Institute) and adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) framework.
Focused question
Two focused questions were formulated using the PECO strategy depending on the direction of the association.
First direction: periodontitis is a risk factor for NCDs.
| Population | (P): | adults. |
| Exposure | (E): | periodontitis. |
| Comparator | (C): | no periodontitis. |
| Outcome | (O): | frequency of periodontitis in individuals with and without NCDs. |
What is the association between periodontitis and NCDs in adults?
Second direction: NCDs are a risk factor for periodontitis.
| Population | (P): | adults. |
| Exposure | (E): | NCDs. |
| Comparator | (C): | no NCDs. |
| Outcome | (O): | frequency of NCDs in individuals with and without periodontitis. |
What is the association between NCDs and periodontitis in adults?
Definition of NCDs
NCDs were defined as the most common systemic diseases that have been associated with periodontitis. To assist with the listing of possible NCDs, an artificial intelligence (AI-ChatGPT 4.0: searched July 24 2024) was used (see Supplementary Material 1). It is important to note that in some instances bidirectionality does not apply according to the current biological plausibility of the studied relationship and therefore was not included in the search.
Inclusion criteria
Only systematic reviews with meta-analysis were included in the review. There was no language restriction, but reviews published in languages other than Spanish or English were translated using an application.
Search strategy
A comprehensive search was conducted by two independent reviewers in MEDLINE (via PubMed), Embase and SciELO, restricted to a timeframe between January 2021 and July 2024, to retrieve the most recent evidence. The Cochrane Database of Systematic Reviews was not searched, as these reviews are included in PubMed and are typically limited to interventions. A list of keywords was used in various combinations (see Supplementary Material 2). The search was automatically restricted by time frame and type of article (i.e., systematic reviews).
Inclusion of systematic reviews
Initially, potential epidemiologic systematic reviews with meta-analysis that studied the bidirectional association between periodontitis and NCDs were identified by two independent reviewers and filtered by title and abstract according to the selection criteria. Subsequently, systematic reviews were selected for full-text review based on these criteria. Full-text articles were then retrieved, reviewed, and included. Any discrepancies between the reviewers were discussed, and if consensus could not be reached, a third reviewer made the final determination on study inclusion. The PRISMA flow diagram was used to illustrate the study selection process.
If multiple systematic reviews were identified for a given disease (e.g., diabetes), only the most recent report that met the inclusion criteria at the time of assessment was included to avoid overlapping. If the most recent systematic review did not meet the inclusion criteria, the next most recent review was considered, and so on. Critically low quality reviews were excluded as well as any other type of review that did not meet the inclusion criteria (e.g. animal studies, in vitro studies). Therefore, a single systematic review with meta-analysis was included for a singular disease depending on the availability of the evidence.
Data extraction
Data was extracted by two independent reviewers using a predetermined form that included: year and author, country of origin, systemic disease, number of studies, number of high risk of bias, number of events and totals in cases and comparator, odds ratio/risk ratio/hazard ratio with 95% confidence intervals, I2, Chi2 (with p value) and publication bias.
Quality assessment of systematic reviews
The quality of the systematic review was classified by two independent reviewers (high 8–11, moderate 4–7, low 0–3) according to the JBI critical appraisal checklist for systematic reviews and research. Although the checklist is not intended as a quantitative tool, it allows to identify potential issues in the design of the systematic reviews that may affect the quality of the results. Any discrepancies between the reviewers were discussed, and if consensus could not be reached, a third reviewer made the final determination on study quality.
Grading the strength and certainty of the evidence
An initial grading of the strength of the association was based on the assessment of the size of the reported effect (odds/risk ratio) according to Rosenberg and Handler [7]. The classification was as follows: none (1.0–1.2), weak (1.2–1.5), moderate (1.5–3.0), and strong (3.0–10.0).
The quality and certainty of the evidence was assessed according to the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) guide. If the systematic review did not include a GRADE assessment, one was performed based on the published data.
Synthesis of effect measurement
All study data were tabulated and presented in the qualitative synthesis. The effect measurement was the reported odds ratio (OR)/relative risk (RR)/hazard ratio (HR) with its 95% confidence interval for each NCD. The Chi² test was used to determine heterogeneity among the included studies, and the I² statistic was applied to estimate its impact. The I² value was categorized as follows: 0–40% indicating mild heterogeneity; 30–60% indicating moderate heterogeneity; 50–90% indicating substantial heterogeneity; and 75–100% indicating very considerable heterogeneity.
The measurements of effect size were plotted according to the strength of the association for each systematic review and NCD.
Results
General characteristics of the systematic reviews
Initially, 561,554 potential results were identified. After removing duplicates and excluding records deemed ineligible by automated filters, 450 results were screened by title and abstract. This process led to 41 records being appraised in full-text. Of these, 17 were further excluded (see supplementary material 3), leaving a total of 24 systematic reviews [8–31] that met the inclusion criteria (Fig. 1).
Fig. 1.
Flow diagram of systematic reviews selection.
Table 1 lists the general characteristics of the included systematic reviews. In total, 32 NCDs were studied and consolidated: pregnancy complications (preterm birth, low birth weight, preeclampsia), cognitive impairment, cardiovascular complications (heart failure, stroke, myocardial infarction, coronary heart disease, atrial fibrillation, atrial flutter), cancers (oral, lung, colorectal, urogenital, gastric, pancreatic), gastrointestinal disease (inflammatory bowel disease, Crohn’s disease, ulcerative colitis), Sjogren’s syndrome, sleep disordered breathing, obesity, dyslipidemia, diabetes, hyperglycaemia, liver disease, osteoporosis, rheumatoid arthritis, chronic obstructive pulmonary disease, metabolic syndrome, systemic lupus erythematosus and kidney disease. In general, the majority of the systematic reviews were registered and publication lag time was 1 year on average. The methods of determining the diagnosis of the NCDs and periodontitis varied among studies but in general used clinical examination, the International Classification of Diseases codes, well established criteria, national records and self-reporting. The number of included studies in the systematic reviews ranged from 3 to 33 and publication bias was evident.
Table 1.
General characteristics of the included systematic reviews.
| Author/year | Register | Country | Disease | Definition of disease | Definition of periodontitis | Last search | Number of included studies | Number of studies high RoB | Pub bias analysis |
|---|---|---|---|---|---|---|---|---|---|
| Castaño-Suarez et al. 2024 | Open Science Framework | Colombia | Preterm birth | Birth before 37 weeks | Clinical examination or periodontal indices | 2023 | 33 | 4 | Yes |
| Low birth weight | Birth weight less than 2500 g | Clinical examination or periodontal indices | |||||||
| Lin et al. 2024 | PROSPERO (CRD42023395297) | China | Cognitive impairment | MMSE, MoCA, The Winblad criteria, NINCDS-ADRDA | Clinical examination or periodontal indices | 2023 | 7 | 0 | No |
| Dewan et al. 2024 | PROSPERO (CRD42021237995) | India | Stroke | Ischemic stroke, hemorrhagic stroke and transient ischemic attacks | CAL > 3 mm and more than 30% of sites involved | 2022 | 36 | 0 | No |
| Ma et al. 2024 | PROSPERO (CRD42023407582) | China | Oral cancer, oral squamous cell carcinoma, oropharyngeal cancer | ICD for oncology | International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) | 2023 | 16 | 2 | Yes |
| Aguiar et al. 2024 | PROSPERO (CRD42021221317) | Brazil | Gastric adenocarcinoma | Self report, medical records, ICD, national registry (histology) | Self report, positive diagnosis, dental history | 2022 | 9 | 0 | Yes |
| Wang et al. 2024 | PROSPERO (CRD42024502981) | China | Inflammatory bowel disease | ICD, Rare and Intractable Diseases | ICD, clinical examination, self reported | 2024 | 6 | 2 | Yes |
| Crohn’s disease | ICD, Rare and Intractable Diseases | ICD, clinical examination, self reported | |||||||
| Ulcerative colitis | ICD, Rare and Intractable Diseases | ICD, clinical examination, self reported | |||||||
| Leelaviwat et al. 2024 | Not stated | USA | Heart failure | Self reported, ICD, European Society of Cardiology | Periodontal profile class, CDC criteria | 2023 | 3 | ND | No |
| Tan et al. 2024 | PROSPERO (CRD42021272876) | Singapore | Systemic lupus erythematosus (SLE) | Systemic Lupus International Collaborating Clinics Criteria; American College of Rheumatology | Periodontal parameters and periodontal indices | 2023 | 43 | 0 | Yes |
| Rheumatoid arthritis (RA) | American College of Rheumatology | Periodontal parameters and periodontal indices | |||||||
| Verma et al. 2023 | PROSPERO (CRD42023390819) | India | Lung cancer | (AECG), the European Community criteria, Copenhagen criteria | Clinical examination or periodontal indices | 2022 | 7 | 0 | Yes |
| Larvin et al. 2023 | PROSPERO (CRD42019154897) | United Kingdom | Diabetes | Clearly defined classification of metabolic, autoimmune or inflammatory diseases | Clinically or self-reported diagnosis or signs of periodontitis | 2022 | 30 | 17 | Yes |
| Kidney disease | Clearly defined classification of metabolic, autoimmune or inflammatory diseases | Clinically or self-reported diagnosis or signs of periodontitis | |||||||
| Liver disease | Clearly defined classification of metabolic, autoimmune or inflammatory diseases | Clinically or self-reported diagnosis or signs of periodontitis | |||||||
| Osteoporosis | Clearly defined classification of metabolic, autoimmune or inflammatory diseases | Clinically or self-reported diagnosis or signs of periodontitis. | |||||||
| Rheumatoid arthritis | Clearly defined classification of metabolic, autoimmune or inflammatory diseases | Clinically or self-reported diagnosis or signs of periodontitis | |||||||
| Yang et al. 2023 | Not stated | China | Chronic obstructive pulmonary disease (COPD) | FEV1, FVC, GOLD, self reported | Clinical examination or periodontal indices | 2023 | 22 | 4 | Yes |
| Rosário-Dos-Santos et al. 2023 | PROSPERO (CRD42021232120) | Brazil | Metabolic syndrome (MetS) | NCEP ATP III, IDF, AHA/NHLBI | Partial or full oral examination, periodontal indices | 2022 | 14 | 0 | Yes |
| Leelaviwat et al. 2023 | Not stated | USA | Atrial fibrillation (AF) and atrial flutter (AFL) | ICD or by a standard 12-lead ECG | ICD-9 M codes for periodontitis, Periodontal profile class | Not stated | 4 | ND | No |
| Leng et al. 2023 | PROSPERO (CRD42022333663) | China | Cardiovascular disease including: myocardial infarction (MI), coronary heart disease (CHD), or stroke in MEN | ICD | Clinical or self-report | 2022 | 26 | 1 | Yes |
| Cardiovascular disease including: myocardial infarction (MI), coronary heart disease (CHD), or stroke in WOMEN | ICD | Clinical or self-report | 2022 | 26 | 1 | Yes | |||
| Yang et al. 2023 | PROSPERO (CRD42021261322) | China | Sjogren´s syndrome | European community criteria, The Copenhagen criteria, American-European consensus group | Periodontal parameters and periodontal indices | 2021 | 21 | 5 | Yes |
| Liu et al. 2023 | Not stated | China | Sleep-disordered breathing (Obstructive sleep apnea) | PSG | Periodontal examination (AAP/CDC definitions) | 2022 | 10 | 0 | Yes |
| Le et al. 2022 | Not stated | Australia | Preeclampsia | blood pressure of ≥140/90 mmHg after 20 weeks of gestation, combined with proteinuria of at least 1+on midstream urine specimen or catheter specimen | ≥ 2 sites with PD ≥ 4 mm and CAL ≥ 3 mm, not on the same site or one site with PD ≥ 5 mm at the same site or evaluated the progression by clinical periodontal parameters | Not stated | 30 | 9 | Yes |
| Xu et al. 2022 | Not stated | China | Pancreatic cancer | ICD | ICD, clinical examination, bone loss | 2021 | 17 | 6 | Yes |
| Li et al. 2022 | PROSPERO (CRD42021244405) | China | Urogenital cancer | Medical records, pathology, ICD, cancer registry | Questionnaires, clinical periodontal examinations and radiographic examinations or other credible forms of medical records were acceptable | 2022 | 11 | 0 | Yes |
| Mirzaei et al. 2022 | Not stated | Iran | Dyslipidemia | TG > 200 mg/dl, TC > 200 mg/dl, HDL < 60 mg/dl, LDL > 30 mg/dl, HDL < 40 mg/dl (men), HDL < 50 mg/dl (women), TG ≥ 150 mg/dl | CAL > 1, PD > 2, and CPI > 2 | 2021 | 31 | 2 | Yes |
| Kim et al. 2022 | PROSPERO (CRD42022301343) | South Korea | Obesity | BMI ≥ 30 kg/m2 or higher, but BMI ≥ 25 kg/m2 in Asians. Waist circumference as ≥88 cm in women and ≥102 cm in men, but ≥90 cm for men and ≥80 cm for women in Asians | (PPD) ≥ 4 mm, clinical attachment level (CAL) ≥ 1 mm, and community periodontal index (CPI) ≥ 3 | 2022 | 37 | 2 | Yes |
| Li et al. 2021 | Not stated | China | Colorectal cancer | ICD | Self reported, CDC-AAP, Russell index, radiographs | 2020 | 7 | 2 | Yes |
| Mirzaei et al. 2021 | Not stated | Iran | Hyperglycaemia | HbA1c > 6% or 7.5% or 9%; Fasting blood glucose >100 or 110 or 120 or 126 mg/dL | Periodontal parameters and periodontal indices | 2021 | 19 | 0 | Yes |
| Zheng et al. 2021 | PROSPERO (CRD42019128053) | China | Type 2 diabetes mellitus | HbA1c > 6.7% or 7%; Fasting blood glucose >126 mg/dL | Periodontal parameters | 2020 | 40 | 2 | Yes |
RoB risk of bias, MMSE Mini-Mental State Examination, MoCA Montreal Cognitive Assessment, The Winblad criteria, NINCDS-ADRDA National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association, ICD International Classification of Diseases, AECG American-European Consensus Group Criteria, FEV1 forced expiratory volume in 1s, FVC forced vital capacity, GOLD Global Initiative for Chronic Obstructive Lung Disease, NCEP ATP III National Cholesterol Education Program - Adult Treatment Panel III, IDF International Diabetes Federation, AHA/NHLBI American Heart Association and the National Heart Lung and Blood Institute, ECG Electrocardiogram, PSG polysomnography, TG triglycerides, TC total cholesterol, HDL high density lipoprotein, LDL low density lipoprotein, BMI body mass index, HbA1C glycated hemoglobin, PD probing depth, CAL clinical attachment loss, AAP American academy of periodontology, CDC Centers for disease control.
The risk of bias assessment indicated that 21 systematic reviews (87.5%) demonstrated low bias (high quality) [8–13, 15–19, 21–27, 29–31], 2 had medium bias [14, 28], and 1 exhibited high bias (low quality) [20]. Key issues identified included the formulation of explicit research questions, critical appraisal, data extraction, and publication bias (Fig. 2 and Supplementary Material 4). Two systematic reviews with meta analysis were published in the format of rapid communication and therefore lacked some information in the methods [14, 20]. However, they were kept since they analyzed the influence of periodontitis on two cardiovascular conditions that were not identified in other reviews.
Fig. 2. Risk of bias assessment of included systematic reviews.
A Shows the frequency distribution of the quality domains. B Shows the general risk of bias of the systematic reviews.
The association between periodontitis and NCDs
The strength of the association between periodontitis and NCDs is presented in Fig. 3. The estimate of the association was strong in 1 systematic review (preeclampsia), moderate in 8 (oral cancer, low birth weight, metabolic syndrome, kidney disease, preterm birth, cognitive impairment, heart failure, liver disease), weak in 10 (colorectal cancer, lung cancer, osteoporosis, pancreatic cancer, atrial fibrillation and flutter, stroke, rheumatoid arthritis, urogenital cancer, diabetes, cardiovascular complications in men), and absent in 7 systematic reviews (chronic obstructive pulmonary disease, gastric adenocarcinoma, dyslipidemia, ulcerative colitis, cardiovascular complications in women, inflammatory bowel disease, Crohn’s disease). The size of the reported effect was broader with increasing strength and this should be interpreted cautiously. Periodontitis significantly increases the odds of preeclampsia (OR 3.18; 95% CI 2.26–4.48), with the confidence interval not including 1, though it appears somewhat wide. This suggests that there is substantial evidence supporting an association between periodontitis and preeclampsia. Conversely, the relative risk (RR) of liver disease is 1.53 (95% CI 0.86–2.73), with a confidence interval that includes 1 and is wide, indicating a moderate but unstable association between periodontitis and liver disease. Finally, the odds ratio for stroke, myocardial infarction, and coronary heart disease in women is 1.11 (95% CI 1.05–1.17), which does not support an association between periodontitis and these cardiovascular events.
Fig. 3. Plot of the strength of the association according to the size of the effect for periodontitis → noncommunicable diseases.
OR odds ratio, HR hazard ratio. 95% confidence interval is shown in parenthesis. LBW low birth weight, MetS metabolic syndrome, PB preterm birth, AF atrial fibrillation, AFL atrial flutter, RA rheumatoid arthritis, MI myocardial infarction, CHD coronary heart disease, COPD chronic obstructive pulmonary disease, GA gastric adenocarcinoma, UC ulcerative colitis, IBD inflammatory bowel disease.
The association between NCDs and periodontitis
The strength of the association between NCDs and periodontitis is depicted in Fig. 4. The estimate of the association was moderate in 6 systematic reviews (systemic lupus erythematosus, Sjogren’s syndrome, Crohn’s disease, sleep disordered breathing, rheumatoid arthritis, type 2 diabetes) and weak in 3 systematic reviews (hyperglycaemia, inflammatory bowel disease, obesity). In general, the reported size of the effect was broader also with increasing strength, which as result impacted the precision of the certainty of the evidence. In summary, the evidence suggests that certain NCDs are associated with periodontitis, but the wider confidence intervals indicate that these findings should be interpreted with caution.
Fig. 4. Plot of the strength of the association according to the size of the effect for noncommunicable diseases → periodontitis.
OR odds ratio, HR hazard ratio. 95% confidence interval is shown in parenthesis.
Certainty of the evidence for the bidirectional association between periodontitis and NCDs
Although data supports the association between periodontitis and NCDs, and to a lesser extent between some NCDs and periodontitis, the certainty of the evidence was classified as low to very low (Tables 2 and 3). This means that our confidence in the effect estimates is very limited and the actual effect is likely to be substantially different from the effect estimate. It is important to note that the level of certainty was primarily downgraded due to potential risks of bias, as well as heterogeneity in both the effect sizes and study methodologies, which impacted the precision of the results.
Table 2.
GRADE assessment of the evidence for periodontitis → noncommunicable diseases.
| Year/author | Disease | Design | Risk of bias | Inconsistency | Indirectness | Imprecision | Pub Bias | Other considerations | Certainty | Importance |
|---|---|---|---|---|---|---|---|---|---|---|
| Aguiar et al. 2024 | Gastric adenocarcinoma | 9 analytical studies | Serious. Several studies carried a large effect | Not serious. Heterogeneity 41.5% | Serious. Information regarding representativeness and comparability of groups was detected | Serious. Confidence intervals are wide in some studies | Not serious | 7/9 studies showed no association between periodontitis and gastric adenocarcinoma | Very low | Important |
| Castaño-Suarez 2024 | Preterm birth | 25 analytical studies | Serious. 4/25 studies carried great weight to the effect. 11/25 studies considered as moderate/high bias | Serious: Heterogeneity 95%, Chi2 510.1 | Serious. Information regarding selection of participants is lacking in some studies | Serious. Confidence intervals are wide in some studies | Serious. Publication bias detected | Some of the studies demonstrated a higher prevalence of periodontitis in the case group compared to the control group | Low | Important |
| Castaño-Suarez 2024 | Low birth weight | 20 analytical studies | Serious. 4/20 studies carried great weight to the effect. 4/20 studies considered as moderate/high bias | Serious: Heterogeneity 93%, Chi2 279.9 | Serious. Information regarding selection of participants is lacking in some studies | Serious. Confidence intervals are wide in some studies | Serious. Publication bias detected | Some of the studies demonstrated a higher prevalence of periodontitis in the case group compared to the control group | Low | Important |
| Dewan et al. 2024 | Stroke | 13 analytical studies | 7/13 studies carried a large effect. risk of bias low to moderate | Not serious. Heterogeneity 30.3% | Serious. Information regarding representativeness and comparability of groups was detected | Serious. Confidence intervals are wide in some studies | Not performed | 2/13 studies showed no association between periodontitis and stroke | Low | Important |
| Leelaviwat et al. 2024 | Heart failure | 3 cohort studies | Serious. risk of bias not reported | Serious. Heterogeneity 78.4% | Incomplete information. | Serious. Confidence intervals are wide in some studies | Not performed | Incomplete information. No RoB analyses and GRADE | Very low | Important |
| Lin et al. 2024 | Cognitive impairment | 7 analytical studies | Serious. 3/7 studies carried great weight to the effect. 5/7 studies considered as moderate bias | Not serious. heterogeneity 0%. Chi2 5.79 | Not serious | Serious. Confidence intervals are wide in some studies | Publication bias analysis not performed due to low number of studies | 5/7 studies showed no association between periodontitis and cognitive impairment | Very low | Important |
| Ma et al. 2024 | Oral cancer, oral squamous cell carcinoma, oropharyngeal cancer | 9 case control studies | Serious. 2 studies high risk of bias | Not serious. Heterogeneity 52.4%. | Serious. Information regarding representativeness and comparability of groups was detected | Serious. Confidence intervals are wide in some studies | Not serious | 2/9 studies showed no association between periodontitis and oral cancer | Low | Important |
| Wang et al. 2024 | Inflammatory bowel disease | 4 cohort studies | Serious. Risk of bias detected in all studies | Not serious. Heterogeneity 27% | Serious. Information regarding representativeness and comparability of groups was detected | Serious. Confidence intervals are wide in some studies | Not serious | Studies show no association between periodontitis and IBD | Very low | Important |
| Wang et al. 2024 | Crohn’s disease | 4 cohort studies | Serious. Risk of bias detected in all studies | Not serious. Heterogeneity 0% | Serious. Information regarding representativeness and comparability of groups was detected | Serious. Confidence intervals are wide in some studies | Not serious | Studies show no association between periodontitis and CD | Very low | Important |
| Wang et al. 2024 | Ulcerative colitis | 4 cohort studies | Serious. Risk of bias detected in all studies | Not serious. Heterogeneity 38% | Serious. Information regarding representativeness and comparability of groups was detected | Serious. Confidence intervals are wide in some studies | Not serious | Some studies showed no association between periodontitis and UC. Otherwise the association is very close to 1 | Very low | Important |
| Larvin et al. 2023 | Diabetes | 9 analytical studies | Serious | Not serious. heterogeneity 53.8%. Q 20.21 | Serious. Information regarding selection of participants is lacking in some studies | Serious. Confidence intervals are wide in some studies | Publication bias suspected | 3/9 studies showed no association between periodontitis and incident diabetes. Otherwise the association is close to 1 | Low | Important |
| Larvin et al. 2023 | Kidney disease | 2 analytical studies | Very serious | Not serious. heterogeneity 0% | Serious. Information regarding selection of participants is lacking in some studies | Serious. Confidence intervals are wide in some studies | Publication bias suspected | Both studies showed significant association between periodontitis and kidney disease | Very low | Important |
| Larvin et al. 2023 | Liver disease | 3 analytical studies | Very serious. 1/3 studies carried a large effect. Confounding factors are important. | Serious: Heterogeneity 91.6%, Q 13.55 | Serious. Information regarding selection of participants is lacking in some studies | Serious. Confidence intervals are wide in some studies | Publication bias suspected | The overall shows no association between periodontitis and liver disease | Very low | Important |
| Larvin et al. 2023 | Osteoporosis | 4 analytical studies | Very serious. 2/4 carried a large effect. Confounding factors are important. | Serious: Heterogeneity 93%, Q 45.07 | Serious. Information regarding selection of participants is lacking in some studies | Serious. Confidence intervals are wide in some studies | None | All studies show association between periodontitis and osteoporosis | Very low | Important |
| Larvin et al. 2023 | Rheumatoid arthritis | 4 analytical studies | Very serious. Confounding factors are important. | Serious. Heterogeneity 72.8%, Q 12.66 | Serious. Information regarding selection of participants is lacking in some studies | Not serious | None | All studies show association between periodontitis and RA | Low | Important |
| Leelaviwat et al. 2023 | Atrial fibrillation (AF) and atrial flutter (AFL) | 3 cohort studies | Unknown since it was not mentioned in the article | Not serious. heterogeneity 3% | Unknown since it was not mentioned in the article | Not serious | Unknown since it was not mentioned in the article | Unknown since it the methods section is very short. Although the confidence interval is narrow, the value is close to 1 | Very low | Important |
| Leng et al. 2023 | Myocardial infarction (MI), coronary heart disease (CHD), or stroke in MEN | 17 analytical studies in men | Not serious. 1 study high risk of bias | Serious. Heterogeneity 93%, Chi2 243.4 | Serious. Information regarding representativeness and comparability of groups was detected | Serious. Confidence intervals are wide in some studies | Not serious | 8/17 studies showed no association between periodontitis and CVD. Otherwise the association is close to 1 | Very low | Important |
| Leng et al. 2023 | Myocardial infarction (MI), coronary heart disease (CHD), or stroke in WOMEN | 9 analytical studies in women | Not serious. 1 study high risk of bias | Serious. Heterogeneity 85%, Chi2 95.8 | Serious. Information regarding representativeness and comparability of groups was detected | Serious. Confidence intervals are wide in some studies | Not serious | Some studies showed no association between periodontitis and CVD. Otherwise the association is very close to 1 | Very low | Important |
| Rosário-Dos-Santos et al. 2023 | Metabolic syndrome (MetS) | 6 analytical studies moderate-severe periodontitis | Serious. Sources of bias included lack of clarity in non-respondents, missing data and sample size calculation. 1/6 studies carried a large effect. | Serious.Heterogeneity 86.1% | Serious: information regarding representativeness of sample population and comparability is lacking | Not serious | Publication bias suspected | 1/6 studies showed no association between periodontitis and MetS | Low | Important |
| Verma et al. 2023 | Lung cancer | 7 analytical studies | 1/7 studies carried a large effect. 3/7 studies considered medium risk of bias | Serious: Heterogeneity 82%, Chi2 33.9 | Serious. Information regarding selection of participants is lacking in some studies | Serious. Confidence intervals are wide in some studies | Publication bias performed with less than 10 studies | 2/7 studies showed no association between periodontitis and lung cancer. Otherwise the association is close to 1 | Very low | Important |
| Yang et al. 2023 | Chronic obstructive pulmonary disease (COPD) | 22 analytical studies | Serious. 3/22 studies carried a large effect and risk of bias high in 4 studies | Serious: Heterogeneity 79%, Chi2 86.21 | Serious. Information regarding representativeness of sample population and comparability is lacking | Serious. Confidence intervals are wide in some studies | None | 9/22 studies showed no association between periodontitis and COPD | Low | Important |
| Le et al. 2022 | Preeclampsia | 28 analytical studies | Very serious. 8/28 studies carried large effect | Serious: Heterogeneity 81%, Chi2 139.03 | Serious. Information regarding comparability is lacking in some studies | Serious. Confidence intervals are wide in some studies | None | 9/28 studies showed no association between periodontitis and preeclampsia | Low | Important |
| Li et al. 2022 | Urogenital cancer | 11 analytical studies | Serious. Several studies carried a large effect. | Not serious. Heterogeneity 22.4% | Serious. Information regarding representativeness and comparability of groups was detected. | Serious. Confidence intervals are wide in some studies | Not serious | 5/11 studies showed no association between periodontitis and urogenital cancer. Otherwise the association is close to 1 | Very low | Important |
| Mirzaei et al. 2022 | Dyslipidemia | 13 analytical studies | Serious. Moderate risk of bias detected in most studies | Not serious. Heterogeneity 28.7% | Serious. Information regarding representativeness and comparability of groups was detected. | Not serious | Not serious | Very low | Important | |
| Xu et al. 2022 | Pancreatic cancer | 14 analytical studies | Serious. High risk of bias in 6 studies | Serious. Heterogeneity 60.8% | Serious. Information regarding representativeness and comparability of groups was detected | Serious. Confidence intervals are wide in some studies | Publication bias suspected | Not serious | Very low | Important |
| Li et al. 2021 | Colorectal cancer | 7 cohort studies | Serious. Several studies carried a large effect. | Serious. Heterogeneity 53.9% | Serious. Information regarding representativeness and comparability of groups was detected | Serious. Confidence intervals are wide in some studies | Not serious | 4/7 studies showed no association between periodontitis and colorectal cancer | Very low | Important |
The Grading of Recommendations Assessment, Development and Evaluation (GRADE).
Table 3.
GRADE assessment of the evidence for noncommunicable diseases → periodontitis.
| GRADE domains | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Year/author | Disease | Design | Risk of bias | Inconsistency (I2) | Indirectness | Imprecision | Pub Bias | Other considerations | Certainty | Importance |
| Tan et al. 2024 | Systemic lupus erythematosus (SLE) | 10 analytical studies | Serious. Some studies carried a very large effect | Serious. Heterogeneity 89%, Chi2 83.6 | Serious. There were issues regarding comparability and selection of participants | Serious. Confidence intervals are wide in some studies | Serious. Publication bias detected | 6/10 studies showed no association between SLE and periodontitis | Very low | Important |
| Tan et al. 2024 | Rheumatoid arthritis (RA) | 29 analytical studies | Serious. 9 studies carried a very large effect | Serious. Heterogeneity 90%, Chi2 282.3 | Serious. There were issues regarding comparability and selection of participants | Serious. Confidence intervals are wide in some studies | Serious. Publication bias detected | 13/29 studies showed no association between RA and periodontitis | Very low | Important |
| Wang et al. 2024 | Inflammatory bowel disease | 2 longitudinal studies | Serious. 1 study carried a large effect. Risk of bias was detected | Not serious. Heterogeneity 18% | Serious. There were issues regarding comparability and selection of participants | No serious. Confidence interval was wide in 1 study. However, the range of the CI was small for over 33,000 individuals | Not determined due to low number of studies | Heterogeneity in study methods may act as a confounding factor | Very low | Important |
| Wang et al. 2024 | Crohn’s disease | 2 longitudinal studies | Serious. 1 study carried a large effect. Risk of bias was detected | Serious. Heterogeneity 81% | Serious. There were issues regarding comparability and selection of participants | Serious. Confidence interval was wide in 1 study | Not determined due to low number of studies | Possible false negatives for CD according to the RIS threshold (required information size) | Very low | Important |
| Yang et al. 2023 | Sjogrens | 5 analytical studies | Serious. 1/5 studies carried a very large effect | Serious. Heterogeneity 77.5% | Serious. There were issues regarding comparability and selection of participants | Serious. Confidence interval was large in one study | Not serious | 3/5 studies showed association between Sjogrens syndrome and periodontitis | Low | Important |
| Liu et al. 2023 | Sleep-disordered breathing (Obstructive sleep apnea) | 10 analytical studies | Serious. 4 studies carried a large effect | Not serious. heterogeneity 40%, Chi2 16.6 | Serious. There were issues regarding comparability and selection of participants | Serious. Confidence intervals wide in 4 studies | Not serious | 4/10 studies showed no association between SDB and periodontitis. Heterogeneity in study methods may act as a confounding factor | Very low | Important |
| Kim et al. 2022 | Obesity | 29 analytical studies | Serious. Several studies carried a large effect. Risk of bias was moderate to low | Serious. Heterogeneity 98%, Chi2 1356.12 | Serious. There were issues regarding comparability and selection of participants | Serious. Confidence interval are wide in several studies | Not serious | 12/29 studies showed no association between obesity and periodontitis | Very low | Important |
| Mirzaei et al. 2021 | Hyperglycaemia | 11 cross-sectional studies | Not serious | Serious. Heterogeneity 84.1% | Not serious | Not serious | Serious. Publication bias detected | Most studies showed association between hyperglycemia and periodontitis | Low | Important |
| Zheng et al. 2021 | Type 2 diabetes mellitus | 16 analytical studies | Serious. 5/16 studies carried a large effect. Studies rated high and moderate risk of bias | Not serious. Heterogeneity 32%, Chi2 22.05 | Serious. There were issues regarding comparability and selection of participants | Serious. Confidence intervals are wide in some studies although combined CI was small | Not serious | 10/16 studies showed no association between diabetes and periodontitis. Heterogeneity in study methods may act as a confounding factor | Low | Important |
High quality: We are very confident that the real effect corresponds to the effect estimate. Moderate quality: We are moderately confident in the effect estimate; The true effect is likely to be close to the effect estimate, but there is a possibility that it will be substantially different. Low quality: our confidence in the effect is limited; the actual effect may be substantially different from the estimated effect. Very low quality: we have very little confidence in the effect estimate; The actual effect is likely to be substantially different from the effect estimate.
The Grading of Recommendations Assessment, Development and Evaluation (GRADE).
Discussion
The results of this umbrella review objectively compile the best available evidence regarding the bidirectional association between periodontitis and systemic health. However, even the highest quality evidence may not always be sufficient to draw definitive conclusions that inform clinical decision-making. To date, aside from the review by Botelho et al. [32], this study is the most recent and specifically addresses the grading of evidence certainty in this area. In addition, it does not focus on biological mechanisms but rather examines data derived from various analytical studies in humans.
Significance of the results
Is periodontitis a risk factor for systemic health complications and vice versa, or is it merely coincidental? The results of this umbrella review indicate that while periodontitis is associated with certain NCDs, it does not establish a causal relationship. The most plausible explanation is that periodontitis and systemic health issues often occur simultaneously and share common inflammatory and microbiological mechanisms. Consequently, the presence of one condition may influence the development of the other. The studies included in this review highlighted the co-occurrence of multiple systemic conditions and confounding factors. Therefore, it is not possible to confirm that periodontitis independently contributes to systemic health complications and vice versa.
Multimorbidity is the presence of two or more chronic conditions in an individual, with no one ailment being regarded as the dominant focus. This phenomenon is becoming more common in aging populations and poses considerable challenges to healthcare systems because of the complexities of addressing many, often interconnected, diseases at the same time. Multimorbidity complicates clinical decision-making while also increasing the strain on patients, who must navigate many therapies and healthcare providers. It is linked to higher healthcare expenses, lower quality of life, and increased mortality, emphasizing the importance of integrated and patient-centered approaches to care. Large population-based studies have demonstrated that a significant proportion of adults—27%—report having two or more chronic conditions, with the prevalence increasing notably with advancing age [33, 34]. In our umbrella review, periodontitis appears to be associated with some systemic chronic diseases (i.e. systemic lupus erythematosus to periodontitis or periodontitis to preeclampsia) and tend to co-occur, primarily because they share common inflammatory mechanisms, as well as genetic, environmental, and sociodemographic determinants. Therefore, periodontitis remains a significant condition in the context of multimorbidity because it has the ability to contribute to and be affected by several chronic diseases. Understanding the link between periodontitis and multimorbidity is critical for establishing holistic care methods that target the underlying causes of these non-communicable chronic diseases to reduce the health impact of aging.
Limitations of this review and perspective
The main limitation of this umbrella review is that the quality of the evidence is inherently influenced by the quality of the original research. Inconsistencies and contradictions among the included studies can complicate the interpretation of the overall findings. Each systematic review identified potential sources of bias, which must be considered when evaluating the results. Consequently, the certainty of the evidence was rated as low. This suggests that the conclusions drawn from the studies should be approached with caution, given the challenges associated with investigating the interactions between periodontitis and systemic conditions in humans.
To enhance the quality of data supporting the link between periodontitis and NCDs, future research should focus on well-designed longitudinal studies that minimize bias and appropriately consider multimorbidity. This involves utilizing statistical models that account for the effects of multiple chronic diseases, as well as employing standardized diagnostic tools. Additionally, to address health disparities and improve overall population health, it is essential to understand how socioeconomic, racial, and ethnic factors influence the prevalence, severity, and accessibility of treatment for both systemic diseases and periodontitis.
Conclusions
There is some data that, with varying degrees of association and low to very low certainty, provide evidence that periodontitis may be a potential risk factor for some NCDs and vice versa.
Supplementary information
Author contribution
JEB and CRM conceived and/or designed the protocol of the review. JEB, CRM, AC and SAS acquired data, conducted risk of bias and grading of the evidence. All authors played an equally important role in interpreting the results and drafting the manuscript.
Funding
Open Access funding provided by Colombia Consortium.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
The online version contains supplementary material available at 10.1038/s41432-025-01132-9.
References
- 1.Belibasakis GN, Belstrøm D, Eick S, Gursoy UK, Johansson A, Könönen E. Periodontal microbiology and microbial etiology of periodontal diseases: Historical concepts and contemporary perspectives. Periodontology. 2023. 10.1111/prd.12473. [DOI] [PubMed]
- 2.Kinane DF, Lappin DF, Culshaw S. The role of acquired host immunity in periodontal diseases. Periodontology. 2024. 10.1111/prd.12562. [DOI] [PubMed]
- 3.WHO. Noncommunicable Diseases. World Health Organization. 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases.
- 4.Monsarrat P, Blaizot A, Kémoun P, Ravaud P, Nabet C, Sixou M, et al. Clinical research activity in periodontal medicine: a systematic mapping of trial registers. J Clin Periodontol. 2016;43:390–400. 10.1111/jcpe.12534. [DOI] [PubMed] [Google Scholar]
- 5.Orlandi M, Muñoz Aguilera E, Marletta D, Petrie A, Suvan J. D’Aiuto F. Impact of the treatment of periodontitis on systemic health and quality of life: A systematic review. J Clin Periodontol. 2022;49:314–27. 10.1111/jcpe.13554. [DOI] [PubMed] [Google Scholar]
- 6.Puljak L, Lund H. Definition, harms, and prevention of redundant systematic reviews. Syst Rev. 2023;12:63. 10.1186/s13643-023-02191-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Rosenberg D, Handler A. Module 2: Measures of association and hypothesis testing. In: Handler A, Rosenberg D, Monahan C, Kennelly J, editors. Analytic Methods in Maternal and Child Health. Washington, D.C.: Division of Science, Education, and Analysis, Health Resources and Services Administration, Maternal and Child Health Bureau; 1998: p.69.
- 8.Castaño-Suárez L, Paternina-Mejía GY, Vásquez‑Olmos LD, Rodríguez-Medina C, Botero JE. Linking Periodontitis to Adverse Pregnancy Outcomes: a Comprehensive Review and Meta-analysis. Curr Oral Health Rep. 2024;11:125–37. 10.1007/s40496-024-00371-6. [Google Scholar]
- 9.Lin J, Pathak JL, Shen Y, Mashrah MA, Zhong X, Chen J, et al. Association between Periodontitis and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis. Dement Geriatr Cogn Disord. 2024;53:37–46. 10.1159/000535776. [DOI] [PubMed] [Google Scholar]
- 10.Dewan M, Pandit AK, Goyal L. Association of periodontitis and gingivitis with stroke: A systematic review and meta-analysis. Dent Med Probl. 2024;61:407–15. 10.17219/dmp/158793. [DOI] [PubMed] [Google Scholar]
- 11.Ma Y, Tuerxun N, Maimaitili G. Periodontitis and the risk of oral cancer: a meta-analysis of case-control studies. Acta Odontol Scand. 2024;83:40478. 10.2340/aos.v83.40478. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Aguiar FJN, Menezes FDS, Fagundes MA, Fernandes GA, Alves FA, Filho JG, et al. Gastric adenocarcinoma and periodontal disease: A systematic review and meta-analysis. Clinics. 2024;79:100321. 10.1016/j.clinsp.2023.100321. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Wang Q, Chen S, Zhou J, Zhao L. Bidirectional associations between periodontitis and inflammatory bowel disease: A systematic review of longitudinal studies with meta-analysis and trial sequential analysis. J Periodontal Res. 2024. 10.1111/jre.13291. [DOI] [PubMed]
- 14.Leelaviwat N, Kewcharoen J, Trongtorsak A, Thangjui S, Del Rio-Pertuz G, Abdelnabi M, et al. Association between periodontal disease and heart failure: a systematic review and meta-analysis. Acta Cardiol. 2024;79:405–09. 10.1080/00015385.2023.2259192. [DOI] [PubMed] [Google Scholar]
- 15.Tan PR, Lee AJL, Zhao JJ, Chan YH, Fu JH, Ma M, et al. Higher odds of periodontitis in systemic lupus erythematosus compared to controls and rheumatoid arthritis: a systematic review, meta-analysis and network meta-analysis. Front Immunol. 2024;15:1356714. 10.3389/fimmu.2024.1356714. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Verma UP, Singh P, Verma AK. Correlation Between Chronic Periodontitis and Lung Cancer: A Systematic Review With Meta-Analysis. Cureus. 2023;15:e36476 10.7759/cureus.36476. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Larvin H, Kang J, Aggarwal VR, Pavitt S, Wu J. Periodontitis and risk of immune-mediated systemic conditions: A systematic review and meta-analysis. Community Dent Oral Epidemiol. 2023;51:705–17. 10.1111/cdoe.12812. [DOI] [PubMed] [Google Scholar]
- 18.Yang M, Peng R, Li X, Peng J, Liu L, Chen L. Association between chronic obstructive pulmonary disease and periodontal disease: a systematic review and meta-analysis. BMJ Open. 2023;13:e067432 10.1136/bmjopen-2022-067432. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Rosário-Dos-Santos HL, Miranda SS, Gomes-Filho IS, Cruz SSD, Figueiredo ACMG, Souza ES, et al. Periodontitis severity relationship with metabolic syndrome: A systematic review with meta-analysis. Oral Dis. 2023;29:2512–20. 10.1111/odi.14428. [DOI] [PubMed] [Google Scholar]
- 20.Leelaviwat N, Kewcharoen J, Poomprakobsri K, Trongtorsak A, Del Rio-Pertuz G, Abdelnabi M, et al. Periodontal disease and risk of atrial fibrillation or atrial flutter: A systematic review and meta-analysis. J Arrhythm. 2023;39:992–96. 10.1002/joa3.12921. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Leng Y, Hu Q, Ling Q, Yao X, Liu M, Chen J, et al. Periodontal disease is associated with the risk of cardiovascular disease independent of sex: A meta-analysis. Front Cardiovasc Med. 2023;10:1114927 10.3389/fcvm.2023.1114927. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Yang B, Pang X, Guan J, Liu X, Li X, Wang Y, et al. The association of periodontal diseases and Sjogren’s syndrome: A systematic review and meta-analysis. Front Med. 2023;9:904638 10.3389/fmed.2022.904638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Liu X, Zhu Z, Zhang P. Association between sleep-disordered breathing and periodontitis: a meta-analysis. Med Oral Patol Oral Cir Bucal. 2023;28:e156–e166. 10.4317/medoral.25627. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Le QA, Akhter R, Coulton KM, Vo NTN, Duong LTY, Nong HV, et al. Periodontitis and Preeclampsia in Pregnancy: A Systematic Review and Meta-Analysis. Matern Child Health J. 2022;26:2419–43. 10.1007/s10995-022-03556-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Xu S, Wang HL, Xia C, Lv J, Zhang G. Associations Between Poor Oral Hygiene and Risk of Pancreatic Cancer: A Meta-analysis of Observational Studies. Pancreas. 2022;51:985–94. 10.1097/MPA.0000000000002143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Li W, Wang S, He Y, Zhang Y, Lin S, Cen D, et al. Is periodontal disease a risk indicator for urogenital cancer? A systematic review and meta-analysis of cohort studies. Front Oncol. 2022;12:697399 10.3389/fonc.2022.697399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Mirzaei A, Shahrestanaki E, Malmir H, Ejtahed HS, Tajbakhsh D, Seif E, et al. Association of periodontitis with lipid profile: an updated systematic review and meta-analysis. J Diabetes Metab Disord. 2022;21:1377–93. 10.1007/s40200-022-01071-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Kim CM, Lee S, Hwang W, Son E, Kim TW, Kim K, et al. Obesity and periodontitis: A systematic review and updated meta-analysis. Front Endocrinol (Lausanne). 2022;13:999455 10.3389/fendo.2022.999455. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Li W, Xu J, Zhang R, Li Y, Wang J, Zhang X, et al. Is periodontal disease a risk indicator for colorectal cancer? A systematic review and meta-analysis. J Clin Periodontol. 2021;48:336–47. 10.1111/jcpe.13402. [DOI] [PubMed] [Google Scholar]
- 30.Mirzaei A, Shahrestanaki E, Daneshzad E, Heshmati J, Djalalinia S, Asayesh H, et al. Association of hyperglycaemia and periodontitis: an updated systematic review and meta-analysis. J Diabetes Metab Disord. 2021;20:1327–36. 10.1007/s40200-021-00861-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Zheng M, Wang C, Ali A, Shih YA, Xie Q, Guo C. Prevalence of periodontitis in people clinically diagnosed with diabetes mellitus: a meta-analysis of epidemiologic studies. Acta Diabetol. 2021;58:1307–27. 10.1007/s00592-021-01738-2. [DOI] [PubMed] [Google Scholar]
- 32.Botelho J, Mascarenhas P, Viana J, Proença L, Orlandi M, Leira Y, et al. An umbrella review of the evidence linking oral health and systemic noncommunicable diseases. Nat Commun. 2022;13:7614 10.1038/s41467-022-35337-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Boersma P, Black LI, Ward BW. Prevalence of Multiple Chronic Conditions Among US Adults, 2018. Prev Chronic Dis. 2020;17:E106. 10.5888/pcd17.200130. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Kuan V, Denaxas S, Patalay P, Nitsch D, Mathur R, Gonzalez-Izquierdo A, et al. Identifying and visualizing multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study. Lancet Digit Health. 2023;5:e16–e27. 10.1016/S2589-7500(22)00187-X. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.